Apex Biotechnology Corp. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 2,198.862 million compared to TWD 2,043.614 million a year ago. Operating income was TWD 203.276 million compared to TWD 227.352 million a year ago. Net income was TWD 113.859 million compared to TWD 95.119 million a year ago. Basic earnings per share was TWD 1.14 compared to TWD 0.95 a year ago. Diluted earnings per share was TWD 1.04 compared to TWD 0.9 a year ago.